Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 4
2005 10
2006 6
2007 8
2008 8
2009 7
2010 8
2011 15
2012 8
2013 8
2014 13
2015 25
2016 23
2017 11
2018 13
2019 11
2020 12
2021 17
2022 14
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
Fedoriw A, Rajapurkar SR, O'Brien S, Gerhart SV, Mitchell LH, Adams ND, Rioux N, Lingaraj T, Ribich SA, Pappalardi MB, Shah N, Laraio J, Liu Y, Butticello M, Carpenter CL, Creasy C, Korenchuk S, McCabe MT, McHugh CF, Nagarajan R, Wagner C, Zappacosta F, Annan R, Concha NO, Thomas RA, Hart TK, Smith JJ, Copeland RA, Moyer MP, Campbell J, Stickland K, Mills J, Jacques-O'Hagan S, Allain C, Johnston D, Raimondi A, Porter Scott M, Waters N, Swinger K, Boriack-Sjodin A, Riera T, Shapiro G, Chesworth R, Prinjha RK, Kruger RG, Barbash O, Mohammad HP. Fedoriw A, et al. Among authors: copeland ra. Cancer Cell. 2019 Jul 8;36(1):100-114.e25. doi: 10.1016/j.ccell.2019.05.014. Epub 2019 Jun 27. Cancer Cell. 2019. PMID: 31257072 Free article.
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.
Italiano A, Soria JC, Toulmonde M, Michot JM, Lucchesi C, Varga A, Coindre JM, Blakemore SJ, Clawson A, Suttle B, McDonald AA, Woodruff M, Ribich S, Hedrick E, Keilhack H, Thomson B, Owa T, Copeland RA, Ho PTC, Ribrag V. Italiano A, et al. Among authors: copeland ra. Lancet Oncol. 2018 May;19(5):649-659. doi: 10.1016/S1470-2045(18)30145-1. Epub 2018 Apr 9. Lancet Oncol. 2018. PMID: 29650362 Clinical Trial.
Novel targets for parkinsonism-depression comorbidity.
Tizabi Y, Getachew B, Csoka AB, Manaye KF, Copeland RL. Tizabi Y, et al. Among authors: copeland rl. Prog Mol Biol Transl Sci. 2019;167:1-24. doi: 10.1016/bs.pmbts.2019.06.004. Epub 2019 Jul 8. Prog Mol Biol Transl Sci. 2019. PMID: 31601399 Review.
The Elements of Translational Chemical Biology.
Copeland RA, Boriack-Sjodin PA. Copeland RA, et al. Cell Chem Biol. 2018 Feb 15;25(2):128-134. doi: 10.1016/j.chembiol.2017.11.003. Epub 2017 Dec 7. Cell Chem Biol. 2018. PMID: 29233521 Free article. Review.
RNA-modifying proteins as anticancer drug targets.
Boriack-Sjodin PA, Ribich S, Copeland RA. Boriack-Sjodin PA, et al. Among authors: copeland ra. Nat Rev Drug Discov. 2018 Jun;17(6):435-453. doi: 10.1038/nrd.2018.71. Epub 2018 May 18. Nat Rev Drug Discov. 2018. PMID: 29773918 Review.
Nicotine and the nicotinic cholinergic system in COVID-19.
Tizabi Y, Getachew B, Copeland RL, Aschner M. Tizabi Y, et al. Among authors: copeland rl. FEBS J. 2020 Sep;287(17):3656-3663. doi: 10.1111/febs.15521. Epub 2020 Aug 25. FEBS J. 2020. PMID: 32790936 Free PMC article. Review.
Small molecule control of chromatin remodeling.
Finley A, Copeland RA. Finley A, et al. Among authors: copeland ra. Chem Biol. 2014 Sep 18;21(9):1196-210. doi: 10.1016/j.chembiol.2014.07.024. Chem Biol. 2014. PMID: 25237863 Review.
Drug Discovery and Chemical Biology of Cancer Epigenetics.
Ribich S, Harvey D, Copeland RA. Ribich S, et al. Among authors: copeland ra. Cell Chem Biol. 2017 Sep 21;24(9):1120-1147. doi: 10.1016/j.chembiol.2017.08.020. Cell Chem Biol. 2017. PMID: 28938089 Free article. Review.
Targeting epigenetic regulators for cancer therapy.
Wee S, Dhanak D, Li H, Armstrong SA, Copeland RA, Sims R, Baylin SB, Liu XS, Schweizer L. Wee S, et al. Among authors: copeland ra. Ann N Y Acad Sci. 2014 Feb;1309:30-6. doi: 10.1111/nyas.12356. Ann N Y Acad Sci. 2014. PMID: 24571255 Review.
230 results